Pulike Biological Engineering, Inc.

Shanghai Stock Exchange 603566.SS

Pulike Biological Engineering, Inc. Interest Coverage Ratio for the year ending December 31, 2023: 173.97

Pulike Biological Engineering, Inc. Interest Coverage Ratio is 173.97 for the year ending December 31, 2023, a -28.80% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Pulike Biological Engineering, Inc. Interest Coverage Ratio for the year ending December 31, 2022 was 244.36, a -81.13% change year over year.
Pulike Biological Engineering, Inc. Interest Coverage Ratio for the year ending December 31, 2021 was 1,295.12, a -62.79% change year over year.
Pulike Biological Engineering, Inc. Interest Coverage Ratio for the year ending December 31, 2020 was 3,481.01, a 1,375.22% change year over year.
Pulike Biological Engineering, Inc. Interest Coverage Ratio for the year ending December 31, 2019 was 235.97, a -15.97% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shanghai Stock Exchange: 603566.SS

Pulike Biological Engineering, Inc.

CEO	Mr. Wei Hu
IPO Date	May 18, 2015
Location	China
Headquarters	No.15 Zhenghe Road
Employees	1,679
Sector	Health Care
Industries Biotechnology Pharmaceuticals Vaccines

Description

Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company is headquartered in Luoyang, China.

Key trends

Past 5 years